![Eugene Kennedy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eugene Kennedy
Directeur Technique/Scientifique/R&D chez CARISMA THERAPEUTICS, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Eugene Kennedy
Sociétés | Poste | Début | Fin |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 02/05/2024 | - |
Historique de carrière de Eugene Kennedy
Anciens postes connus de Eugene Kennedy
Sociétés | Poste | Début | Fin |
---|---|---|---|
GALERA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2022 | 01/09/2023 |
LUMOS PHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/01/2014 | 06/03/2021 |
Thomas Jefferson University | Corporate Officer/Principal | 01/01/2006 | 01/12/2013 |
Innovative Cellular Therapeutics, Inc. | Directeur Technique/Scientifique/R&D | - | - |
The Hope Funds for Cancer Research
![]() The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Directeur/Membre du Conseil | - | - |
LUMOS PHARMA, INC. | Directeur Technique/Scientifique/R&D | 14/11/2017 | - |
Formation de Eugene Kennedy
University of Virginia | Undergraduate Degree |
Medical College of Virginia | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
LUMOS PHARMA, INC. | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
CARISMA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
NewLink Genetics Corp.
![]() NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
The Hope Funds for Cancer Research
![]() The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Commercial Services |
Innovative Cellular Therapeutics, Inc. |
- Bourse
- Insiders
- Eugene Kennedy
- Expérience